Pharmaceutical composition for the treatment of bone fracture

Details for Australian Patent Application No. 2005260327 (hide)

Owner Dong Wha Pharmaceutical Co., Ltd.

Inventors Ku, Sae Kwang; Ryu, Jei Man; Lee, Jin Soo; Lee, Jung Woo; Yang, Hee Bog

Agent Wrays

Pub. Number AU-B-2005260327

PCT Pub. Number WO2006/004369

Priority 10-2004-0052069 05.07.04 KR

Filing date 5 July 2005

Wipo publication date 12 January 2006

Acceptance publication date 1 October 2009

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 19/00 (2006.01) Drugs for skeletal disorders

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/004369 Priority application(s): WO2006/004369

27 August 2009 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Dong Wha Pharmaceutical. Ind. Co., Ltd. to Dong Wha Pharmaceutical Co., Ltd.

1 October 2009 Application Accepted

  Published as AU-B-2005260327

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260328-Composition for the prevention and treatment of allergic inflammatory disease

2005260326-An improved process for preparing Nhydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) - phenoxy] -pentoxy }-benzamidine